Life365 has developed a breakthrough Cloud-Based Connected Care Platform that combines remote health monitoring, in-home diagnostic testing and family care coordination. It’s goal is to shift the Point of Care from clinical settings to the home in a way that is both affordable and easy. The technology is comprised of wearable sensors and wireless technologies with SaaS solutions and engagement analytics to connect patients with their healthcare professionals in a cost-effective manner. The company ensures that patient data is seamlessly and securely integrated into healthcare systems while remaining HIPAA compliant. The need for this technology is demonstrated by the push to drive…
Author: Alexandra Barnes
Lattice Biologics (TSX-V: LBL) (OTCBB: BLVKF) announced an increase in the size of its non-brokered private placement, from $750,000 to $1.5M in response to high investor demand. As a result, the funding raise will be extended for an additional 30 day period. After the close of the private placement’s third tranche, Lattice issued 2,556,235 units (one unit is equivalent to one common share of capital stock and one-half of one common share purchase warrant) at $0.20CAN each, creating gross proceeds in the sum of $390,000USD. After this latest closing, total investor funding is up to $690,000USD. Proceeds from the placement will…